- Home
- LKCO vs PMCB Comparison
LKCO vs PMCB Comparison
Compare LKCO & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LKCO
- PMCB
- Stock Information
- Founded
- LKCO 2009
- PMCB 1996
- Country
- LKCO China
- PMCB United States
- Employees
- LKCO N/A
- PMCB N/A
- Industry
- LKCO EDP Services
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LKCO Technology
- PMCB Health Care
- Exchange
- LKCO Nasdaq
- PMCB Nasdaq
- Market Cap
- LKCO 11.9M
- PMCB 11.4M
- IPO Year
- LKCO N/A
- PMCB N/A
- Fundamental
- Price
- LKCO $0.81
- PMCB $1.32
- Analyst Decision
- LKCO
- PMCB
- Analyst Count
- LKCO 0
- PMCB 0
- Target Price
- LKCO N/A
- PMCB N/A
- AVG Volume (30 Days)
- LKCO 134.3K
- PMCB 15.1K
- Earning Date
- LKCO 10-22-2024
- PMCB 03-17-2025
- Dividend Yield
- LKCO N/A
- PMCB N/A
- EPS Growth
- LKCO N/A
- PMCB N/A
- EPS
- LKCO N/A
- PMCB 1.29
- Revenue
- LKCO $5,389,818.00
- PMCB N/A
- Revenue This Year
- LKCO N/A
- PMCB N/A
- Revenue Next Year
- LKCO N/A
- PMCB N/A
- P/E Ratio
- LKCO N/A
- PMCB $1.00
- Revenue Growth
- LKCO N/A
- PMCB N/A
- 52 Week Low
- LKCO $0.80
- PMCB $1.22
- 52 Week High
- LKCO $7.68
- PMCB $2.55
- Technical
- Relative Strength Index (RSI)
- LKCO 19.43
- PMCB 40.04
- Support Level
- LKCO $1.39
- PMCB $1.22
- Resistance Level
- LKCO $1.74
- PMCB $1.40
- Average True Range (ATR)
- LKCO 0.34
- PMCB 0.12
- MACD
- LKCO -0.13
- PMCB -0.03
- Stochastic Oscillator
- LKCO 2.81
- PMCB 31.06
About LKCO Luokung Technology Corp
Luokung Technology Corp is a spatial-temporal intelligent big data services company, as well as a provider of LBS for various industries in China. It has established city-level and industry-level holographic spatial-temporal digital twin systems and actively serves industries including smart transportation (autonomous driving, smart highway and vehicle-road collaboration), natural resource asset management (carbon neutral and environmental protection remote sensing data service), and LBS smart industry applications (mobile Internet LBS, smart travel, smart logistics, new infrastructure, smart cities, emergency rescue, among others).
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.